Going Underground: Demographics, Services, and Best Practices Endorsed by Practitioners Providing Support for Naturalistic Psychedelic Use
- 19 September 2024
- journal article
- research article
- Published by Taylor & Francis in Journal of Psychoactive Drugs
- Vol. 57 (5) , 475-485
Abstract
Psychedelic-assisted therapy (PAT) has shown preliminary efficacy for psychiatric and physical health conditions. Although some people report naturalistic psychedelic use with so-called "underground" practitioners, little is known about PAT that occurs outside of controlled clinical settings or perspectives of these practitioners. We conducted an anonymous online survey of individuals who reported providing psychedelic support services (e.g. trip sitting and/or preparatory/follow-up psychotherapy) in naturalistic settings. We investigated demographics, including education and licensing, details about services provided, and reported client outcomes. Among 107 participants, 40.2% held a full or in-progress license and 44.9% had not obtained a relevant graduate degree. Almost all participants reported pre-screening clients before treatment, offering preparation, integration, and trip-sitting services, and most employed a range of therapeutic modalities, centering primarily on non-directive approaches. Participants reported that clients most commonly consumed psilocybin, and treated numerous conditions, primarily aligning with indications targeted in psychedelic clinical research. Perceptions of clients' symptom changes were largely positive, although a small proportion reported worsened personality disorder symptoms. Further research delineating client and practitioner perspectives of naturalistic PAT services is warranted, and such work may shed light on the benefits and risks specific to naturalistic PAT as well as inform best practices for practitioners.Keywords
Funding Information
- Michigan Psychedelic Society, Founder/Executive
- National Institutes of Health (K01DA049219 (KFB))
- National Institutes of Health
This publication has 35 references indexed in Scilit:
- Psychedelic-assisted psychotherapy: where is the psychotherapy research?Psychopharmacology, 2024
- Single-Dose Psilocybin Treatment for Major Depressive DisorderJAMA, 2023
- Emerging Challenges for Psychedelic TherapyJAMA Psychiatry, 2023
- Preparing for the Bursting of the Psychedelic Hype BubbleJAMA Psychiatry, 2022
- A Research Domain Criteria (RDoC)-Guided Dashboard to Review Psilocybin Target Domains: A Systematic ReviewCNS Drugs, 2022
- Percentage of Heavy Drinking Days Following Psilocybin-Assisted Psychotherapy vs Placebo in the Treatment of Adult Patients With Alcohol Use DisorderJAMA Psychiatry, 2022
- Applying Lessons From Cannabis to the Psychedelic HighwayJAMA Health Forum, 2022
- RETRACTED ARTICLE: MDMA-assisted psychotherapy for treatment of PTSD: study design and rationale for phase 3 trials based on pooled analysis of six phase 2 randomized controlled trialsPsychopharmacology, 2019
- Novel psychoactive substances of interest for psychiatryWorld Psychiatry, 2015
- Acceptance and Commitment Therapy: Model, processes and outcomesBehaviour Research and Therapy, 2006